Angiogenesis and vascular permeability modulators and inhibitors
CA 2395136 A1 · Owner: Eliceiri, Brian · Inventors: Cheresh, David A.; Paul, Robert; Eliceiri, Brian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention describes methods for modulating vascular permeability (VP) in tissues using Src or modified Src protein Yes protein or modified Yes , protein, Src family tyrosine kinase protein inhibitors and nucleic acids , capable of expression of Src or modified Src protein Yes protein or modified , Yes protein, and Src family tyrosine kinase protein inhibitors or mixtures , thereof. The invention also describes methods for inhibiting VP using an inactive Src or Yes protein or a mixture thereof or CSK protein or modified , CSK protein or nucleic acids encoding therefor, or by using chemical Src family tyrosine kinase inhibitors such as PP1 PP2, PD173955, AGL1872, PD162531, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 22, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 22, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.